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Improved living conditions, food security and particularly access to comprehensive health-
care systems have resulted in a continuous increase of the human life expectancy. However, 
living longer does not immediately mean that quality of life can be maintained into old age, 
which is commonly compromised by disease. The full benefit of a longer life can only be 
realised when the later stages of life can be enjoyed in good health. This has generated 
strong demand for new innovative foods that are not only safe and nutritious but also have 
health enhancing properties. Genetic modification technology provides a direct approach to 
enhance existing attributes that are beneficial for human health, minimize any undesirable 
characteristics or enable the introduction of novel, health promoting traits. Focused on milk 
as an important human food source, we will review the humble beginnings of testing 
transgenic approaches with mouse models, transfer of these simple overexpression 
strategies into livestock species, application of programmable nucleases for the targeted 
modifications of milk characteristics and discuss future opportunities that are becoming 
feasible with today’s sophisticated technologies. 
INTRODUCTION 
Milk is a complex biological fluid that evolved to provide a single source of balanced 
nutrition able to support the growth and survival of all mammalian offspring. Because of its 
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quality nutrition with health promoting characteristics. Dairy milk is consumed not only in its 
raw form but is also processed into many different dairy foods, including yoghurt and 
cheese. However, nature has optimised dairy milk for the nutritional demands of calves, 
lambs and kids and hence, is not specifically tailored to provide the best possible benefits 
for human consumption. The advent of transgenic technology with the ability to make 
targeted changes to the composition of milk made it feasible to improve dairy milk for 
human consumption. It immediately triggered intensive discussions on possible strategies to 
improve the overall composition of milk, the fatty acid composition of milk fat as well as 
individual milk proteins (Boland et al. 1992; Jimenez-Flores and Richardson 1988; Wilmut et 
al. 1990). Since then, the technical capabilities for the efficient and precise modification of 
livestock genomes have advanced tremendously (Laible et al. 2015; Tan et al. 2016). In the 
following we will provide a brief summary of past and current efforts and what may be 
possible in the near future.  
TRANSGENIC MOUSE MODELS WITH IMPROVED MILK CHARACTERISTICS 
Initially these concepts could only be tested in mouse models which showed the feasibility 
of overexpressing the major milk proteins from livestock species (Wall et al. 1997). Correct 
incorporation of recombinant livestock caseins into the casein micelles of mouse milk 
further validated this approach (Gutierrez-Adan et al. 1996; Hiripi et al. 2000; Hitchin et al. 
1996; Persuy et al. 1995). Compared to cows’ milk, human milk contains much higher 
amounts of the two anti-microbial whey proteins: lysozyme and lactoferrin. Overexpression 
of the human forms of lysozyme (Maga et al. 1998) and lactoferrin (Seyfert et al. 1996) was 
tested in mouse models to demonstrate the feasibility of humanizing the milk of another 
species to provide additional health benefits by boosting passive immunity following 
consumption. In addition, different strategies were investigated to address lactose-
intolerance. This affects more than 70% of adult consumers of cows’ milk and causes 
intestinal disorders due to inadequate intestinal lactase activity levels resulting in 
insufficient lactose digestion after the consumption of milk (Sahi 1994). As alternatives to 
expensive post-harvest milk processing two strategies for reducing the milk lactose content 
were evaluated in transgenic mouse models. Disruption of the gene encoding α-lactalbumin, 
which is an essential component of the lactose synthetase complex, resulted in lactose-free 
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lack of lactose resulted in highly viscous milk and inability of the transgenic mice to sustain 
lactation and adequate nutrition for the suckling young. To dissect the impacts of osmolarity 
and lactose levels Jost and co-workers overexpressed a mammalian lactose hydrolysing 
enzyme in the mammary gland (Jost et al. 1999). With this approach, milk lactose levels 
were reduced by 50-85% but because lactose was converted into the osmotically active 
monosaccharides, glucose and galactose, this did not interfere with the osmolarity of the 
milk.  
In addition to proteins and carbohydrates, milk fat is an important nutritional component of 
milk that has significant impact on human health. Like other animal fats, milk fat has a high 
content of saturated fatty acids which are considered ‘unhealthy’ and have been associated 
with cardiovascular and coronary heart disease. Hence, reducing unhealthy, saturated fats 
in favour of healthier unsaturated fats is a major target for the improvement of dairy 
products. A promising concept was the complementation of transgenic mice with a 
desaturase, normally not found in vertebrates, which would enable the transgenic mice to 
endogenously synthesise essential poly-unsaturated fatty acids. Indeed, conversion of 
dietary derived n-6 fatty acids into omega-3 poly-unsaturated fatty acids, known for 
lowering the risk of morbidity and mortality from atherosclerosis and coronary heart 
disease, could be achieved with the expression of the n-3 fatty acid desaturase from 
Caenorhabditis elegans following the insertion of the fat-1 gene (Kang et al. 2004; Kao et al. 
2006). 
TRANSFER OF EARLY CONCEPTS FROM MOUSE TO LIVESTOCK 
The early mouse models can only be regarded as feasibility studies that validated the principle 
concepts for changing individual milk components. Because the composition of milk, and with 
it the closely linked functional characteristics of milk, varies greatly between different 
species, the true effects on changes to the composition of the milk, any associated nutritional 
and health benefits and potential impact on the processing characteristics of the milk 
resulting from any direct changes to milk components ought to be assessed in dairy animals 
as the ultimate target species for producing dairy foods for human consumption. 
The concept of overexpressing a milk protein was first transferred to livestock for an 
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Transgenic sows that overexpressed bovine α-lactalbumin in their milk could markedly 
improve the survival rates of suckling piglets and hence increases the overall efficiency of pig 
production (Wheeler et al. 2001). In an attempt to improve milk for human consumption, the 
human variant of α-lactalbumin was overexpressed in cows’ milk (Wang et al. 2008). Analyses 
of the milk showed no apparent changes to the abundance of endogenous milk proteins when 
compared to milk produced by wild-type cows with nutritional benefits expected from the 
additional human α-lactalbumin in the milk. Casein represents 80 % of the protein content of 
milk and essentially constitutes the milk component that makes up cheese when milk is 
processed into cheese. Casein’s nutritional importance and relevance for the processing of 
milk makes it a highly valuable milk component. To increase casein content, cheese yield and 
improve milk processing properties, bovine - and -casein were overexpressed in transgenic 
cattle (Brophy et al. 2003). This resulted in a threefold increase in -casein whilst -casein 
and total protein levels were only modestly elevated. The increased levels for these two 
caseins were associated with complex changes in the abundance of endogenous milk 
proteins, milk fat content and composition and mineral balance (Laible et al. 2016). The 
enhanced content of sialic acid, considered to be an important nutrient for the developing 
brain and the augmented levels of beneficial micronutrients such as calcium, magnesium and 
zinc underlines the milk’s potential for improved health characteristics. The impact of the 
changed milk composition on the physicochemical properties, important for dairy processing, 
was immediately noticeable with a marked difference in the colour of the milk produced by 
the transgenic cows compared with wild-type, and by the substantially reduced size of the 
main protein particles in milk, the casein micelles (Laible et al. 2016; Laible et al. 2007). To 
determine whether these changes may have a positive effect on different milk processing 
processes needs further investigation. Other pioneering studies were aimed at enhancing the 
abundance of milk proteins with anti-microbial activity. Overexpression of the human forms 
of lysozyme and lactoferrin in goats and cattle further improved the health benefits of dairy 
milk by boosting innate defence mechanisms against pathogenic microorganisms (Cooper et 
al. 2015). A longer shelf life of the milk and protection of lactating animals against mastitis-
causing pathogens as a consequence of increased levels of these anti-microbial proteins in 
milk provide further evidence for the milk’s health-promoting effects (Maga et al. 2006; 




National Institutes of Bioscience Journal 2016, Vol. 1    
http://www.nibjournal.ed.ac.uk/   http://dx.doi.org/10.2218/natlinstbiosci.1.2016.1744 
The concept of engineering a dairy animal for the production of healthier milk fat was first 
explored with transgenic goats. The mammary gland-specific overexpression of the key 
enzyme involved in converting saturated fatty acids into mono-unsaturated fatty acids, 
stearoyl-CoA desaturase, improved the milk fat composition by increasing the levels of 
unsaturated fatty acids and lowering the amounts of saturated fatty acids (Reh et al. 2004). 
However, the transgenic goats were unable to sustain the altered fatty acid ratios possibly 
due to instabilities of the transgene-derived mRNA. Enabling livestock with the endogenous 
production of omega-3 fatty acids, which are highly beneficial for human health and mainly 
available through the consumption of oily fish, provides a new, more sustainable food 
source for omega-3 fatty acids and was demonstrated in pigs, sheep and cattle (Lai et al. 
2006; Saeki et al. 2004; Zhang et al. 2013; Cheng et al. 2015). Transgenic cattle, 
constitutively expressing the Caenorhabditis elegans fat1 gene that was optimised for 
mammalian expression, produced milk with high levels of omega-3 poly-unsaturated fatty 
acids and strongly reduced levels of the n-6 fatty acids (Wu et al. 2012). 
For many years, technical limitations restricted the modification of livestock genomes to the 
overexpression of transgenes that were integrated into random chromosomal sites (Laible 
et al. 2015). Although still based on a simple overexpression strategy, the expression of 
small interfering RNAs to degrade or block specific mRNAs offers a relatively simple way to 
modulate the activity of an endogenous gene. The concept was verified in cattle with the 
expression of artificial microRNAs designed to target the mRNA for the bovine milk protein 
gene for β-lactoglobulin (Jabed et al. 2012). Milk produced by a cow expressing the 
microRNAs under the control of a milk protein promoter no longer contained detectable 
levels of β-lactoglobulin, a major allergen in cows’ milk.  
 
 
ENGINEERING MILK PHENOTYPES WITH PROGRAMMABLE NUCLEASES  
The recent development of programmable nucleases has lifted most of the technical 
limitations and enabled the efficient, site-specific modification of livestock genomes (Tan et 
al. 2016). These nucleases, including zinc finger nucleases (ZFNs), transcription activator-like 
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(CRISPR) – CRISPR-associated nuclease 9 (Cas9), can be designed to target a unique site in 
the genome where they introduce a DNA double strand break. This induces the error-prone 
non-homologous end joining (NHEJ) repair mechanism or, in the presence of a homologous 
repair template, can facilitate homology-directed repair (HDR). Repair of DNA double strand 
breaks by NHEJ frequently generates small deletions and insertions (indels), which can be 
utilised to disrupt genes, while HDR can be employed to modify a genomic locus with full 
precision, including insertions of specific mutations or knock-ins of transgenes. To reduce 
the allergenicity of cows’ milk, ZFN-induced NHEJ was applied to disrupt the gene for β-
lactoglobulin. The live calf that was produced was biallelically modified at the target site. 
However, both introduced mutations were small in-frame deletions still permitting the 
production of a truncated form of β-lactoglobulin, potentially still retaining the allergenic 
properties (Yu et al. 2011). The use of a HDR-based strategy ensures a more predictable 
outcome with the insertion of a defined mutation. This approach was recently verified by 
the TALEN-mediated introduction of a pre-mature stop codon at the beginning of the gene 
for β-lactoglobulin directly in bovine embryos (Wei et al. 2015). The efficient knock-in 
capabilities through the application of programmable nucleases were also used to humanise 
goats’ milk and improve its nutritional characteristics. The human milk protein genes for 
lactoferrin and α-lactalbumin were knocked-in to endogenous milk protein genes in goats 
essentially replacing the endogenous milk protein β-lactoglobulin with a different human 
whey protein (Cui et al. 2015; Zhu et al. 2016). In addition, cattle were generated with a 
knock-in of the human lysozyme gene into the bovine β-casein locus albeit for providing 
protection for the lactating cow against infections of the mammary gland rather than 
primarily for nutritional reasons (Liu et al. 2014). 
NEW OPPORTUNITIES GENERATED BY TECHNOLOGICAL ADVANCEMENTS 
Genome editing with programmable nucleases makes it possible to very efficiently 
introduce natural mutations that have been shown to be causatively linked to specific 
phenotypes. This was recently exemplified with the introduction of the POLLED mutation 
known from beef cattle into dairy cattle (Carlson et al. 2016). Importantly, genome editing 
leaves no technological footprint, rendering the edited mutation indistinguishable from a 
naturally occurring mutation. Based on rapidly growing sequence information on individual 
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to identify sequence variants, or in other words mutations, that are causatively linked with a 
specific trait. Because milk production and composition are important traits with economic 
relevance, tremendous efforts go into the discovery of causative traits with relevance for 
milk. At present, only a small number of causative mutations with impact on milk have been 
identified. One such already characterised mutation is a lysine to alanine substitution in the 
DGAT1 gene which results in increase milk fat content (Grisart et al. 2004; Spelman et al. 
2002). However, it can be expected that this number will rapidly increase in the coming 
years providing many new candidates for the improvement of milk. Once causative 
mutations are known, they can be directly introgressed by genome editing into elite genetic 
backgrounds of high performing dairy cattle, fast-tracking the efficient production of milk 
with improved characteristics. Undesirable characteristics, such as allergenicity can be 
addressed by disrupting the relevant gene function which was exemplified for β-
lactoglobulin (Wei et al. 2015). If the immune-reactive regions of the proteins have been 
identified, it would even be possible to just delete the encoding sequence for the allergenic 
epitope to minimise any changes to the overall composition of the milk. HDR with 
programmable nucleases provides now also an efficient method to humanise milk by 
replacing the endogenous milk protein gene variants of dairy animals with the 
corresponding human gene variants which might be better suited for human consumption. 
An alternative approach which does no longer rely on naturally evolved variants could 
involve the generation of entirely novel variants. Milk proteins could be improved through 
rational design with the aim of increasing the nutritional value and digestibility of the 
protein component in milk or enhance processability of milk into various dairy products. 
Milk proteins are also a source of bioactive peptides that are released during digestion and 
could be engineered to increase the availability of these peptides which could then be 
modified to serve as vaccines (Whitelaw et al. 2016). Similarly, specific nutritional 
requirements could be addressed by modifying milk proteins to optimise their content of 
essential amino acids or tailor amino-acid contents according to specific dietary conditions 
such as low phenylalanine for sufferers of phenylketonuria who cannot metabolise the 
amino acid (Laible 2009). Thus, this technology offers a unique opportunity to address 
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CONCLUSION  
Transformational improvements of the technical abilities to genetically modify livestock 
with precision and efficiency makes it now feasible to better customise dairy milk for human 
consumption. However, technological interference with animal derived foods through 
genetic modification has been tarnished by low public acceptance. Overwhelming scientific 
evidence supports the view that the technology carries no more risk than other commonly 
practised food production technologies (Anon 2010). It will be up to the scientists to provide 
compelling evidence of the safety of any new products to consumers and to the welfare of 
production animals and, more importantly, to invent novel products that offer very clear 
consumer benefits to change today’s predominant consumer perception. However, for 
consumers to have the choice they deserve and the opportunity to decide for themselves, 
these products would need to be available for purchase. This will only be possible when the 
present regulatory uncertainties are replaced with a predicable regulatory approval 
pathway to market.  
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